University of Maryland launches institute for vaccine development and malaria treatment
The new institution will expand the school's reach and position among the worldwide health research, prevention and treatment industry. The institute, which will be home to the university's Center for Vaccine Development and Center for Malaria Research. Renowned scientists and researchers have been invited to continue their work at the new institute.
"This will truly be a landmark initiative for the School of Medicine," vice president for medical affairs at the University of Maryland E. Albert Reece said. "As a result of the tireless work of Dr. (Myron) Levine, Dr. (Christopher) Plowe and others, we have continued to grow our global presence now in 35 countries around the world, including research and treatment facilities in Mali, Chile, Malawi and now emerging in Myanmar. This new institute will enable us to leverage all of the tremendous work that has been done, and will have a powerful and lasting impact on global health.
“We are privileged to now have very strong and world-renowned new leadership that will carry the mantle forward,” Reece said. “Dr. Plowe and Dr. (Kathleen) Neuzil represent two of the top visionary scientists and thinkers in both malaria research and vaccine development today. Dr. Plowe has dedicated virtually his entire career to eradicating malaria around the world, working with researchers across the globe and training young scientists and clinical investigators, and building research capacity in countries where malaria is common. Dr. Neuzil is one of the most influential research scientists and advocates in the area of vaccine development and public policy in the world. It is quite fitting that Dr. Plowe and Dr. Neuzil will 'stand on the shoulders' of Dr. Levine to continue to expand the School of Medicine's efforts that have improved the health of millions of citizens around the world.”